Status:
UNKNOWN
Intensive Care Anxiety in SARS-CoV-2 Patients
Lead Sponsor:
Derince Training and Research Hospital
Conditions:
Anxiety
Eligibility:
All Genders
18+ years
Brief Summary
It should be known by the clinician that COVID-19 patients are prone to anxiety, and these disorders need to be properly diagnosed and addressed to improve prognosis, shorten hospital stay and avoid l...
Eligibility Criteria
Inclusion
- Above 18 years old
- COVID PCR +,
- admitted to intensive care,
- conscious, cooperative patients
Exclusion
- Having hearing and speaking problems,
- Can't speak Turkish or English,
- who do not have the cognitive level to understand and answer the questions,
- Communication problems such as dementia and Alzheimer's,
- patients receiving sedation
Key Trial Info
Start Date :
January 17 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 15 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04715477
Start Date
January 17 2021
End Date
April 15 2021
Last Update
January 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
İlke Küpeli
İzmit, Kocaeli̇, Turkey (Türkiye)